2m 2m 2m 2m 2m 2m 2m
THERAPEUTICSMD (TXMD)
NASDAQ
$1.86+$0.005 (+0.27%)
Price as of Oct 22, 2026 7:30 PM EDT- $22.0MMarket Cap
- 55.74%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
THERAPEUTICSMD (TXMD)
$1.86+$0.005 (+0.27%)
TXMD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.85 | ||
Change | +$0.02 (+1.06%) | ||
Open | $1.88 | ||
High | $1.89 | ||
Low | $1.85 | ||
Previous Close | $1.90 | ||
Volume | 5,654 | ||
30-Day Average Volume | 22,316 | ||
1-Week Change | -3.55% | ||
1-Month Change | -9.52% | ||
1-Year Change | 55.74% | ||
3-Year Change | -16.67% | ||
5-Year Change | -95.18% | ||
Fundamentals | |||
Shares Outstanding | 11.6M | ||
Total Assets | $37.5M | ||
Market Cap | $22.0M | ||
Enterprise Value | $12.8M | ||
Period: QTR TTM FY | |||
Revenue | $869,000.00 | ||
Net Income | $164,000.00 | ||
Free Cash Flow | $770,000.00 | ||
EBIT | $164,000.00 | ||
EBITDA | $259,000.00 | ||
Net Working Capital | $11.1M | ||
EPS | $0.01 | ||
Enterprise Value/EBITDA | 49 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 1 | ||
P/E | 190 | ||
PEG | N/A | ||
Price/Free Cash Flow | 29 | ||
Price/Operating Cash Flow | 29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 05/09/2022 | ||
Earnings & Revenue